R

Revolution Medicines
D

RVMD

39.140
USD
-0.62
(-1.56%)
مغلق
حجم التداول
67,077
الربح لكل سهم
-5
العائد الربحي
-
P/E
-10
حجم السوق
7,290,511,672
أصول ذات صلة
A
ADMA
-1.510
(-7.40%)
18.890 USD
A
ALLO
-0.06500
(-4.76%)
1.30000 USD
BNTX
BNTX
-1.400
(-1.32%)
104.960 USD
C
CRSP
1.580
(3.80%)
43.190 USD
E
EDIT
-0.02000
(-0.93%)
2.13500 USD
MRNA
MRNA
-0.475
(-1.82%)
25.555 USD
N
NTLA
0.61500
(6.86%)
9.58500 USD
S
SGMO
-0.01250
(-2.52%)
0.48260 USD
VRTX
VRTX
-8.77
(-1.95%)
442.01 USD
المزيد
الأخبار المقالات

العنوان: Revolution Medicines

القطاع: Healthcare
الصناعة: Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.